Are GLP-1 Drugs a Miracle or a Menace? Lawsuits Spark Fiery Debate Over Safety
Updated January 28, 2026, 8:43 a.m. ET
Imagine losing your sight, enduring excruciating stomach paralysis, or facing life-altering intestinal blockages – all potentially linked to a medication touted as a weight-loss wonder. This is the chilling reality for thousands of patients now suing pharmaceutical giants over the alleged side effects of GLP-1 drugs like Ozempic, Wegovy, and Mounjaro. But here's where it gets controversial: while these lawsuits paint a grim picture, millions swear by these drugs for their transformative health benefits. So, are GLP-1s a medical breakthrough or a ticking time bomb? Join us as we delve into the shocking allegations, the science behind the controversy, and the stories of those forever changed by these medications.
On today’s episode of The Excerpt, USA TODAY Investigative Reporter Austin Fast joins host Dana Taylor to dissect the mounting lawsuits and the drug manufacturers’ responses. Since 2023, over 4,200 patients have filed claims, alleging severe injuries ranging from stomach paralysis to sudden blindness. But what’s the truth behind these claims? And how are companies like Novo Nordisk and Eli Lilly defending their products?
Stomach Paralysis: A Silent Epidemic?
One of the most alarming allegations is stomach paralysis, a condition where the stomach muscles weaken, halting food digestion. Austin explains, “It’s not just about feeling full quickly; it’s nausea, vomiting, bloating, and pain – with no known cure.” While dietary changes can help manage symptoms, the long-term impact remains unclear. And this is the part most people miss: some plaintiffs claim their symptoms persisted even after stopping the medication.
Gruesome Symptoms and Emergency Room Visits
Beyond stomach paralysis, plaintiffs describe intestinal obstructions so severe they’ve led to fecal vomiting – a horrifying reality for one Kentucky man who visited the hospital a dozen times. Others allege gallbladder issues, neurological damage, and even sudden blindness, or “eye strokes,” caused by blocked blood flow to the optic nerve. These aren’t just minor side effects; they’re life-altering conditions.
The Human Cost: Stories That Haunt
Take Todd Engel, a 63-year-old Maryland man who took Ozempic for diabetes. Within months, he lost vision in one eye, and ten months later, the other. Now legally blind, he can no longer work. Or Johelen McClain, a 72-year-old real estate agent whose colon ruptured without warning after taking Wegovy. She now lives with a stoma, a valve in her torso for waste collection, causing anxiety and depression. These aren’t isolated cases – they’re part of a growing chorus demanding answers.
Drug Makers Respond: Denial or Responsibility?
Novo Nordisk and Eli Lilly deny the claims, insisting their drugs are safe and vowing to defend their reputation. They’ve updated European labels to warn of eye stroke risks but maintain American labels are sufficient. Critics argue this isn’t enough, especially as lawsuits pile up. Are these companies prioritizing profits over patient safety? Or are they being unfairly targeted for rare side effects?
The Bigger Picture: Benefits vs. Risks
While the allegations are terrifying, experts highlight GLP-1s’ benefits: weight loss, blood sugar control, reduced risk of substance abuse, and even lower dementia risk. Dr. [Name], a VA Hospital researcher, believes the benefits outweigh the risks for most patients – but stresses the importance of monitoring symptoms and consulting doctors.
What’s Next? A Long Road to Justice
Plaintiffs face hurdles, including strict medical test requirements for stomach paralysis claims. Bellwether trials aren’t expected until 2027, leaving many in limbo. But for those affected, it’s not just about compensation – it’s about stronger warnings and accountability. Would you have taken these drugs knowing the potential risks?
The Debate Rages On
As GLP-1 use surges – with 12% of American adults currently using them – the debate intensifies. Are these drugs a miracle for millions, or a danger lurking in plain sight? We want to hear from you. Do the benefits outweigh the risks? Should drug companies be held more accountable? Share your thoughts in the comments below. The conversation is just beginning.
